$24.75
-0.16-0.64%
In chiusura: -
$25.00
0.251.01%
After hour: Oct 17, 7:53 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Intellia Therapeutics Inc (NASDAQ:NTLA) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 34.14M a 29.74M. Questo rappresenta il 31.38% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Intellia Therapeutics Corp (XNAS:NTLA) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 8.17M azioni scambiate al giorno, ci vorrebbero 3.64 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
29.74M
Vendite allo scoperto %
31.4%
Giorni di copertura
3.64
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. Co | 09/30/2025 | 10/09/2025 | 31.38% | 94,763,719 | 29,739,035 | 8,171,291 | 3.64 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 36.02% | 94,763,719 | 34,137,856 | 4,330,394 | 7.88 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 29.27% | 94,763,719 | 27,737,890 | 3,669,340 | 7.56 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 29.26% | 94,763,719 | 27,729,214 | 4,868,956 | 5.7 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 31.35% | 94,763,719 | 29,708,601 | 5,014,474 | 5.92 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 31.72% | 91,000,227 | 28,867,302 | 4,661,964 | 6.19 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 33.11% | 91,000,227 | 30,130,358 | 4,907,825 | 6.14 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 32.63% | 91,000,227 | 29,689,496 | 5,037,494 | 5.89 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 34.68% | 91,000,227 | 31,557,488 | 6,136,529 | 5.14 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 33.74% | 91,000,227 | 30,704,048 | 3,534,966 | 8.69 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 31.59% | 91,000,227 | 28,748,798 | 2,995,848 | 9.6 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 31.30% | 91,085,914 | 28,509,745 | 3,935,301 | 7.24 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 29.57% | 91,085,914 | 26,937,869 | 3,461,771 | 7.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 29.30% | 91,085,914 | 26,688,670 | 3,107,843 | 8.59 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 28.58% | 91,085,914 | 26,035,739 | 4,291,777 | 6.07 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 27.31% | 89,417,026 | 24,418,372 | 2,602,497 | 9.38 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 26.90% | 89,417,026 | 24,057,390 | 2,940,809 | 8.18 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 26.91% | 89,417,026 | 24,060,839 | 3,313,752 | 7.26 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 24.23% | 89,417,026 | 21,668,143 | 2,467,818 | 8.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 22.15% | 89,417,026 | 19,807,004 | 2,117,088 | 9.36 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 21.15% | 89,417,026 | 18,914,793 | 3,246,797 | 5.83 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 18.30% | 89,417,026 | 16,365,436 | 2,530,308 | 6.47 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 18.06% | 89,417,026 | 16,151,411 | 3,322,227 | 4.86 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 18.35% | 89,147,642 | 16,360,769 | 1,868,829 | 8.75 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 16.99% | 89,147,642 | 15,142,172 | 1,533,472 | 9.87 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 16.56% | 89,147,642 | 14,759,250 | 1,368,514 | 10.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 15.37% | 89,147,642 | 13,703,315 | 977,317 | 14.02 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 15.00% | 89,147,642 | 13,370,113 | 1,473,944 | 9.07 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 16.48% | 84,043,875 | 13,848,364 | 1,516,358 | 9.13 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 15.77% | 84,043,875 | 13,251,610 | 2,266,513 | 5.85 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 16.35% | 84,043,875 | 13,741,636 | 1,897,200 | 7.24 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 17.49% | 84,043,875 | 14,695,539 | 1,499,221 | 9.8 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 18.05% | 84,043,875 | 15,167,458 | 1,452,817 | 10.44 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 18.37% | 84,043,875 | 15,439,289 | 1,141,639 | 13.52 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 17.37% | 84,007,062 | 14,590,490 | 1,260,973 | 11.57 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 17.29% | 85,789,397 | 14,833,304 | 1,071,483 | 13.84 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 15.74% | 85,789,397 | 13,502,755 | 1,539,986 | 8.77 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 14.71% | 85,789,397 | 12,616,622 | 2,336,086 | 5.4 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 13.55% | 85,789,397 | 11,626,877 | 1,674,215 | 6.94 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 13.85% | 79,237,883 | 10,971,169 | 1,436,577 | 7.64 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 13.19% | 79,237,883 | 10,451,029 | 1,358,418 | 7.69 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 12.83% | 79,237,883 | 10,163,815 | 1,376,353 | 7.38 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 13.25% | 79,237,883 | 10,500,937 | 1,712,386 | 6.13 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 12.44% | 79,237,883 | 9,854,501 | 1,450,801 | 6.79 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 11.96% | 79,237,883 | 9,474,918 | 1,850,347 | 5.12 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 12.31% | 78,173,942 | 9,625,691 | 1,436,243 | 6.7 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 10.38% | 78,173,942 | 8,116,361 | 946,400 | 8.58 |
In cerca di azioni più vendute allo scoperto?